MDxHealth S.A. (MDXH)
MDXH Stock Price Chart
Explore MDxHealth S.A. interactive price chart. Choose custom timeframes to analyze MDXH price movements and trends.
MDXH Company Profile
Discover essential business fundamentals and corporate details for MDxHealth S.A. (MDXH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
4 Nov 2021
Employees
312.00
Website
https://mdxhealth.comCEO
Michael K. McGarrity
Description
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
MDXH Financial Timeline
Browse a chronological timeline of MDxHealth S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Nov 2025
EPS estimate is -$0.12.
Earnings released on 5 Aug 2025
EPS came in at -$0.15 falling short of the estimated -$0.13 by -15.38%, while revenue for the quarter reached $26.61M , beating expectations by +1.13%.
Earnings released on 14 May 2025
EPS came in at -$0.19 falling short of the estimated -$0.13 by -46.15%, while revenue for the quarter reached $24.29M , missing expectations by -3.46%.
Earnings released on 26 Feb 2025
EPS came in at -$0.14 surpassing the estimated -$0.21 by +33.33%, while revenue for the quarter reached $24.74M , beating expectations by +9.15%.
Earnings released on 6 Nov 2024
EPS came in at -$0.40 falling short of the estimated -$0.27 by -48.15%, while revenue for the quarter reached $23.32M , beating expectations by +9.79%.
Earnings released on 21 Aug 2024
EPS came in at -$0.31 falling short of the estimated -$0.26 by -19.23%, while revenue for the quarter reached $22.16M , beating expectations by +6.43%.
Earnings released on 1 May 2024
EPS came in at -$0.31 falling short of the estimated -$0.30 by -3.33%, while revenue for the quarter reached $19.83M , missing expectations by -1.91%.
Earnings released on 6 Mar 2024
EPS came in at -$0.39 falling short of the estimated -$0.11 by -254.55%, while revenue for the quarter reached $19.40M , beating expectations by +6.93%.
Stock split effective on 14 Nov 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Nov 2023
EPS came in at -$0.40 falling short of the estimated -$0.31 by -29.03%, while revenue for the quarter reached $19.35M , beating expectations by +5.45%.
Earnings released on 23 Aug 2023
EPS came in at -$0.30 surpassing the estimated -$0.32 by +6.25%, while revenue for the quarter reached $16.75M , beating expectations by +10.01%.
Earnings released on 15 May 2023
EPS came in at -$0.05 surpassing the estimated -$0.40 by +87.50%, while revenue for the quarter reached $14.70M , beating expectations by +8.42%.
Earnings released on 8 Mar 2023
EPS came in at -$1.10 falling short of the estimated -$0.75 by -46.67%, while revenue for the quarter reached $12.89M , missing expectations by -9.73%.
Earnings released on 27 Oct 2022
EPS came in at -$0.05 surpassing the estimated -$0.55 by +90.91%, while revenue for the quarter reached $11.15M .
Earnings released on 25 Aug 2022
EPS came in at -$0.70 falling short of the estimated -$0.55 by -27.27%, while revenue for the quarter reached $6.90M .
Earnings released on 27 Apr 2022
EPS came in at -$0.05 surpassing the estimated -$0.55 by +90.91%, while revenue for the quarter reached $6.11M .
Earnings released on 2 Mar 2022
EPS came in at -$0.66 falling short of the estimated -$0.47 by -41.02%, while revenue for the quarter reached $6.01M .
Earnings released on 5 Nov 2021
EPS came in at -$0.63 , while revenue for the quarter reached $5.50M .
Earnings released on 30 Jun 2021
EPS came in at -$0.60 , while revenue for the quarter reached $5.67M .
Earnings released on 31 Mar 2021
EPS came in at -$0.60 surpassing the estimated -$1.30 by +53.85%, while revenue for the quarter reached $5.06M , missing expectations by -57.83%.
Earnings released on 31 Dec 2020
EPS came in at -$0.83 , while revenue for the quarter reached $4.29M .
Earnings released on 30 Sept 2020
EPS came in at -$0.83 surpassing the estimated -$1.50 by +44.76%, while revenue for the quarter reached $4.29M , missing expectations by -51.25%.
MDXH Stock Performance
Access detailed MDXH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.